Mirtazapin

Mirtazapine (trade name Remeron, among others) is an antidepressant substance of the piperazinoazepine class. At high doses, it has been reported to act as an atypical psychedelic and sedative. It is classified as a noradrenergic and specific serotonergic antidepressant (NaSSA).

Also known as: Avanza, Norset, Zispin, Remeron, Remergil, Org 3770, Mepirzapine, Mirtazapinum, 6-Azamianserin

Classification

Chemical: Medicine
Psychoactive: Depressant
Tag: Pharmaceutical

Effects

Sedation
Dry Mouth
Lightheadedness
Fatigue
Insomnia
Incoordination
Anxiety Suppression
Calmness
Increased Appetite
Dizziness
Drowsiness
Anxiety
Visual Trails
Morphing
Surface Breathing
Warmth
Blurred Vision
Drifting

Routes of Administration

Oral

Dosage

Bioavailability: 250 mg
Threshold: 7.5–15 mg (sedative/off‑label insomnia)
Light: 70 - 130 mg
Common: 130 - 190 mg
Strong: 190 - 250 mg
Heavy: 250 mg

Duration

Onset: 1-2 h
Peak: 3-6 h
Offset: 12-24 h
After Effects: 12-24 h
Total Duration: 12-24 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu